CHRW
53
3
KSS
42
4
FLR
60
4
NSC
53
6
SLB
45
4
PDCO
41
3
WMB
63
3
AEE
55
5
AMGN
42
-5
ALLE
44
5
C
54
4
HP
41
5
AAP
30
3
COST
54
4
IVZ
52
6
PH
71
4
ROST
57
3
VRTX
62
10
EMN
49
3
PFG
36
3
CHRW
53
3
KSS
42
4
FLR
60
4
NSC
53
6
SLB
45
4
PDCO
41
3
WMB
63
3
AEE
55
5
AMGN
42
-5
ALLE
44
5
C
54
4
HP
41
5
AAP
30
3
COST
54
4
IVZ
52
6
PH
71
4
ROST
57
3
VRTX
62
10
EMN
49
3
PFG
36
3
Financhill
Back

Cytokinetics Stock Price Chart

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Sell
49

CYTK
Cytokinetics

Last Price:
55.63
Seasonality Move:
12.68%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CYTK is experiencing buying pressure, which is a positive indicator for future bullish movement.

Cytokinetics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 51.67 Buy
20-day SMA: 53.22 Sell
50-day SMA: 54.14 Sell
200-day SMA: 61.3 Sell
8-day EMA: 52.06 Buy
20-day EMA: 52.83 Sell
50-day EMA: 53.92 Sell
200-day EMA: 55.59 Sell

Cytokinetics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.77 Sell
Relative Strength Index (14 RSI): 47.02 Sell
Chaikin Money Flow: 625350 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.87 - 55.13) Sell
Bollinger Bands (100): (52.82 - 56.94) Sell

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Cytokinetics Stock

Is Cytokinetics Stock a Buy?

  • Cytokinetics share price is 52.52 while CYTK 8-day simple moving average is 51.67, which is a Buy signal.
  • The stock price of CYTK is 52.52 while Cytokinetics 20-day SMA is 53.22, which makes it a Sell.
  • Cytokinetics 50-day simple moving average is 54.14 while CYTK share price is 52.52, making it a Sell technically.
  • CYTK stock price is 52.52 and Cytokinetics 200-day simple moving average is 61.30, creating a Sell signal.

CYTK Technical Analysis vs Fundamental Analysis

Sell
49
Cytokinetics (CYTK) is a Sell

Is Cytokinetics a Buy or a Sell?

  • Cytokinetics stock is rated a Sell
    The current Cytokinetics [CYTK] share price is $52.52. The Score for CYTK is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.

Cytokinetics Stock Info

Market Cap:
6.18B
Price in USD:
52.52
Share Volume:
1.14M

Cytokinetics 52-Week Range

52-Week High:
110.25
52-Week Low:
30.68
Sell
49
Cytokinetics (CYTK) is a Sell

Cytokinetics Share Price Forecast

  • What is the Cytokinetics stock price today?
    The Cytokinetics stock price is 52.52 USD today.
  • Will CYTK stock go up or go down?
    Cytokinetics> share price is forecast to RISE/FALL based on technical indicators
  • Is Cytokinetics overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cytokinetics is overvalued.

Is Cytokinetics Stock a Buy?

  • Cytokinetics share price is 52.52 while CYTK 8-day exponential moving average is 52.06, which is a Buy signal.
  • The stock price of CYTK is 52.52 while Cytokinetics 20-day EMA is 52.83, which makes it a Sell.
  • Cytokinetics 50-day exponential moving average is 53.92 while CYTK share price is 52.52, making it a Sell technically.
  • CYTK stock price is 52.52 and Cytokinetics 200-day simple moving average is 55.59, creating a Sell signal.

Fundamental Analysis of Cytokinetics

Is Cytokinetics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.28 per share, and an increase next year of $0.22 per share.

Technical Analysis of Cytokinetics

Should I short Cytokinetics stock?

* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.